EUVIMEDEUVIMED entdecken
Crossref

Spatial Transcriptomics Reveals Immune Remodeling in Recurrent Oligodendroglioma 2259684

Julia Louw, Kenan Zhang, Anna Corcoran, Elizabeth Owens, Jodie Jepson, Jose Conejo-Garcia, David Ashley, Kanish Mirchia, David Raleigh, Mustafa Khasraw

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Julia Louw und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Oligodendrogliomas frequently recur despite standard therapy, but how the immune microenvironment evolves during recurrence remains poorly understood.

Methods

Visium Spatial Transcriptomics data from primary and matched recurrent oligodendrogliomas from 14 patients were processed using SpaceRanger and deconvoluted with SpaCET’s low-grade glioma model to estimate cell-type proportions. Cell-type fractions were normalized using Centered Log-Ratio transformation and clustered (k = 5, Euclidean distance) to define reproducible spatial niches. Immune subset distributions were compared between primary and recurrent tumors to assess niche-specific remodeling, with propensity score matching applied to control for baseline clinical and molecular differences between treated and untreated patients.

Results

Five spatial niches were identified, including immune-enriched perivascular and infiltrative regions. Recurrent tumors showed marked loss of adaptive immunity, with downregulation of CD4+ T-helper subsets (Th1, Th2, Th17, Tfh; log₂FC ≈ —3) and total CD4+ T cells (—2.9). This loss, most pronounced after radiation and/or chemotherapy, indicates therapy-associated collapse of adaptive immune niches. Macrophage and microglial populations were preserved or increased, reflecting a shift toward a myeloid-dominant, immunosuppressive microenvironment. Immune-rich perivascular regions exhibited depletion of T-helper diversity and enhanced myeloid signaling, consistent with immune exclusion and vascular remodeling. These findings persisted after propensity score matching, with treated tumors remaining enriched for immunosuppressive niches (p < 0.05). Validation by Xenium spatial transcriptomics and CODEX multiplex imaging will be included in the final presentation.

Conclusion

Recurrent oligodendrogliomas exhibit collapse of adaptive immune niches and expansion of myeloid-dominant regions, defining immune remodeling as a hallmark of recurrence and myeloid-driven immunosuppression as a potential therapeutic target. Funding Source n/a Topic Categories Computational and Systems Immunology (COMP)

Zitieren

APA

Louw, J., Zhang, K., Corcoran, A., Owens, E., Jepson, J., Conejo-Garcia, J., Ashley, D., Mirchia, K., Raleigh, D., & Khasraw, M. (2026). Spatial Transcriptomics Reveals Immune Remodeling in Recurrent Oligodendroglioma 2259684. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.763

Vancouver

Louw J, Zhang K, Corcoran A, Owens E, Jepson J, Conejo-Garcia J, et al. Spatial Transcriptomics Reveals Immune Remodeling in Recurrent Oligodendroglioma 2259684. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.763

BibTeX
@article{Louw2026,
  author = {Louw, Julia and Zhang, Kenan and Corcoran, Anna and Owens, Elizabeth and Jepson, Jodie and Conejo-Garcia, Jose and Ashley, David and Mirchia, Kanish and Raleigh, David and Khasraw, Mustafa},
  title = {Spatial Transcriptomics Reveals Immune Remodeling in Recurrent Oligodendroglioma 2259684},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.763}
}
Kostenlos starten →